Search

Out-of-hospital cardiac arrest (OHCA) is a major public health issue that poses significant challenges both in immediate management and long-term follow-up. Survivors of OHCA often experience a combination of complex medical, physical and psychological needs that have a significant impact on quality of life. Guidelines suggest a multi-dimensional follow-up to address both physical and non-physical domains for survivors. However, it is likely that there is substantial unwarranted variation in provision of services throughout the UK. Currently, there is no nationally agreed model for the follow-up of OHCA survivors and there is an urgent need for a set of standards and guidelines in order to ensure equal access for all. Accordingly, the British Cardiovascular Interventional Society established a multi-disciplinary working group to develop a position statement that summarises the most up-to-date evidence and provides guidance on essential and desirable services for a dedicated follow-up pathway for survivors of OHCA., Competing Interests: Disclosure: NC is President of the British Cardiovascular Intervention Society and is on the editorial board of Interventional Cardiology: Reviews, Research, Resources; this did not influence peer review. In the last 36 months; NC has received grants from Haemonetics, HeartFlow, Boston Scientific and Beckmann Coulter Diagnostics and speaker fees from Abbott, Boston Scientific and Edwards. JD has received speaker fees from AstraZeneca. NP has received grants from Heart Research UK. TK has received grants from Abbott Vascular and Treumo, consulting fees from BD and honoraria from AstraZeneca and Abbott Vascular. TQ has received grants from the National Institute for Health Research and the British Cardiovascular Society and is a Non-Executive Director of the NHS Ambulance Trust and Trustee for the British Association for Immediate Care. VO has received speaker fees from Bristol Myers Squibb and Pfizer. All other authors have no conflicts of interest to declare. Funding: This work was partly funded by a King's College Hospital R & D Grant and was supported by the Department of Health through a National Institute for Health Research Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK., (Copyright © 2022, Radcliffe Cardiology.)

Out-of-hospital cardiac arrest (OHCA) affects 80,000 patients per year in the UK; despite improvements in care, survival to discharge remains lower than 10%. NHS England and several societies recommend all resuscitated OHCA patients be directly transferred to a cardiac arrest centre (CAC). However, evidence is limited that all patients benefit from transfer to a CAC, and there are significant organisational, logistic and financial implications associated with such change in policies. Furthermore, there is significant variability in interventional cardiovascular practices for OHCA. Accordingly, the British Cardiovascular Interventional Society established a multidisciplinary group to address variability in practice and provide recommendations for the development of cardiac networks. In this position statement, we recommend: the formal establishment of dedicated CACs; a pathway of conveyance to CACs; and interventional practice to standardise our approach. Further research is needed to understand the role of CACs and which interventions benefit patients with OHCA to support wide-scale changes in networks of care across the UK., Competing Interests: Disclosure: GC has received research grants and consultancy fees from Sedana Medical AB and consultancy fees from BD. NC has received grants from Haemonetics, HeartFlow, Boston Scientific and Beckmann Coulter Diagnostics, as well as speaker fees from Abbott, Boston Scientific and Edwards. NC is president of the British Cardiovascular Intervention Society and is on the editorial board for Interventional Cardiology: Reviews, Research Resources this did not influence peer review. NP has received research grants from Heart Research UK. TK has received research grants from Abbott Vascular and Terumo, consulting fees from BD and speaker fees from Astra Zeneca and Abbott Vascular. TQ is non-executive director of the NHS Ambulance Trust and trustee for the British Association for Immediate Care. The other authors have no conflicts of interest to declare. Funding: This work was funded, in part, by a King's College Hospital R&D Grant and was supported by the Department of Health through a National Institute for Health Research Biomedical Grant, awarded to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK., (Copyright © 2022, Radcliffe Cardiology.)